Chairman, Longmore 60 Biotech Inc, California, USA, E-mail: [email protected]
Visit for more related articles at Research & Reviews in Pharmacy and Pharmaceutical Sciences
Conference Series LLc LTD is organizing “2nd International Conference on Biosimilars & Pharmaceuticals” which is going to be held in the month of February 12-13, 2020 Auckland, New Zealand. The Theme of the conference is “Recent Advancements & New horizons in Biosimilars through a decade”. The conference offers Prestigious Award for Young Research’s at Pharma Biosimilars 2020- Gathering the New-born Advances in Biosimilars.
Pharma Biosimilars 2020 invites research scholars & young scientists, to submit the nominations for Young Scientist Awards: Pharma Biosimilars 2020. This Pharma Biosimilars 2020 Young Scientist Awards will be announced at the upcoming “2nd International Conference on Biosimilars & Pharmaceuticals” at Auckland, New Zealand on February 12-13, 2020.
This Pharma Biosimilars 2020 is an initiative of Conference Series to recognize and provide incentives to the Young Researchers who has shown great potential at their respective field of research. We at Conference Series always encourage the young budding minds to start their career in the field of research and innovations. The core of our Young Research Forum – Young Scientist Awards is to motivate the scholars to present their research ideas in front of the global experts and enhance their knowledge at our international platform. We at Pharma Biosimilars 2020 provide the best networking experience to the participant for their overall professional growth and to promote the collaborative research.
Pharma Biosimilars 2020 Conference will be an investigation of new research Innovation in the field of Biosimilars and Pharmaceuticals and spread the most recent advancements in Biologics Preparation. Discussion on new technology advancement in the field of Pharmaceuticals, current practices in Biosimilars, Regulatory affairs, Pharmacovigilance, Bio-equivalence assessment, Biologics, Biosimilars & Biologics, Drug design theory and more. Detecting Biologics and other Biosimilars conditions, involves a team of healthcare professionals, of which the Biologics technologist is a key player. The market is mainly driven by the increasing research funding for Biosimilars from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for Biosimilars testing.
Encounter the target market with members from across the globe, committed to learn about novel technologies and innovations in Pharmaceuticals. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations distribute and update knowledge about the advancements in Bio-equivalence, Pharmacovigilance, and Drug Design theory and in different fields of Pharmaceuticals by receiving name recognition at this 2-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Cardiology are the principal features of this conference.
The “International Conference on Biosimilars & Pharmaceuticals” hosted by conference series with the theme, “Essential Innovations in Biosimilars “was successfully executed during February 28, March 01, 2020 Osaka, Japan. The conference offered a unique opportunity to investigators across the globe in order to meet, explore, network and perceive new scientific innovations. The conference received commendable and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the global scientists, Professors, Academicians, Researcher Scholars and students from diverse fields of Pharmaceuticals and Bio Technology
The Pharma Biosimilars 2020: Young Scientist Awards: is for all young Researchers, Research Scholars (Preferably PhD, Post Doc, and Postgraduates & Graduates) who has involved themselves into the R&D sector. The candidates should have minimum 3+ years of research experience and published minimum 3 research articles in international journals. Part time researchers can be considered subject to recommended by the research guide or any director level designated person from the organization.Applications are invited on first come first serve basis. Only 25 nominations will be accepted globally.
Nominated candidates need to present their research or talk for 25-30 minutes in front of the panel members. Subject should be under the scope of the Pharma Biosimilars 2020 conference. Selection will be on the basis of individual accomplishments, quality & standards of research, noble thought, research methodology, innovative ideas, style of presentation, significance of the contribution to the field, originality, clarity, and future extended scope of the research and probability of bringing the research in terms of products/services into public domain.
We invite online applications from desired candidates, self-nomination or nominated by organizations (both private & public sectors)/research guides. The student must be the first author & the student’s advisor should attach a statement that their contribution is primarily advisory. Candidates applying for the Pharma Biosimilars 2020: Young Researcher Award should send their resume, along with a letter of recommendation (from a research adviser/faculty/organization heads) to [email protected]. Along with the online application at Pharma Biosimilars 2020 Award page
This award will be presented at Auckland, during Pharma Biosimilars 2020 conference.
Conference Series LLc LTD is the world’s leading specialist in organizing Academic, Scientific and Business conferences, meetings, symposiums and exhibitions in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business to promote scientific research. Every year we host more than 3000+ global events inclusive of 1000+ Conferences 1000+ Symposiums 1000+ Workshops in USA, Europe, Middle East and Asia with the generous support and cooperation from our 30000+ Editorial Board Members, 1000+ Scientific Societies. All the conference proceedings are published in the special issues of our 700+ Open Access International Journals with the DOI provided by CROSSREF.
Program Manager | Pharma Biosimilars 2020
WhatsApp No.: +441157180281
Email: [email protected].